Article Details

bluebird bio Announces FDA Priority Review of Biologics License Application for eli-cel ...

Retrieved on: 2021-12-18 14:01:42

Tags for this article:

Click the tags to see associated articles and topics

bluebird bio Announces FDA Priority Review of Biologics License Application for eli-cel .... View article details on hiswai:

Excerpt

... autotemcel (eli-cel, Lenti-D®), the company's gene therapy for cerebral adrenoleukodystrophy (CALD) in patients less than 18 years of age.

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up